JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB97212

Goat Anti-Human IgA alpha chain (Alkaline Phosphatase)

Be the first to review this product! Submit a review

|

(7 Publications)

Suitable for ICC, IHC-P, ELISA, WB. Cited in 7 publications.

View Alternative Names

Immunoglobulin heavy constant alpha 1, Ig alpha-1 chain C region, Ig alpha-1 chain C region BUR, Ig alpha-1 chain C region TRO, IGHA1

Key facts

Host species

Goat

Target species

Human

Target isotype

IgA

Target specificity

Alpha chain

Minimal cross-reactivity
Pre-adsorbed

No

Conjugation

Alkaline Phosphatase

Excitation/Emission
Applications

WB, ELISA, IHC-P, ICC

applications

Clonality

Polyclonal

Isotype

IgG

Specificity

By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgA. Cross reactivity with other immunoglobulins and light chains is less than 0.1%.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "ICC": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "IHC-P": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/100 - 1/1000", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/10000", "notes":"<p>(Primary ELISA)</p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"1/1000 - 1/10000", "notes":"<p>(Chemiluminescent)</p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
Antiserum was solid phase adsorbed to ensure class specificity. This antibody was isolated by affinity chromatography using antigen coupled to agarose beads and conjugated to Alkaline Phosphatase (AP).
Storage buffer
pH: 6.8 - 7.4 Preservative: 0.09% Sodium azide Constituents: 1.19% HEPES, 0.58% Sodium chloride, 0.2% BSA, 0.0095% Magnesium chloride, 0.00136% Zinc chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens (PubMed : 20176268, PubMed : 22158414). The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen (PubMed : 17576170, PubMed : 20176268). Ig alpha is the major immunoglobulin class in body secretions (PubMed : 2241915).
See full target information IGHA1

Additional targets

IGHA2

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

BMC infectious diseases 24:1042 PubMed39333882

2024

High transmission of endemic human coronaviruses before and during the COVID-19 pandemic in adolescents in Cebu, Philippines.

Applications

Unspecified application

Species

Unspecified reactive species

Janet O Joseph,Michelle Ylade,Jedas Veronica Daag,Rosemary Aogo,Maria Vinna Crisostomo,Patrick Mpingabo,Lakshmanane Premkumar,Jacqueline Deen,Leah C Katzelnick

PLOS global public health 2:e0000619 PubMed36962464

2023

SARS-CoV-2 seroprevalence and risk factors among meat packing, produce processing, and farm workers.

Applications

Unspecified application

Species

Unspecified reactive species

Melissa D Klein,Michael Sciaudone,David Richardson,Roberto Lacayo,Colleen M McClean,Oksana Kharabora,Katherine Murray,Miriana Moreno Zivanovich,Stephen Strohminger,Rachel Gurnett,Alena J Markmann,D Ryan Bhowmik,Emperatriz Morales Salgado,Edwin Castro-Arroyo,Allison E Aiello,Ross M Boyce,Jonathan J Juliano,Natalie M Bowman

IJID regions 7:164-169 PubMed37034427

2023

Seroepidemiology and risk factors for SARS-CoV-2 infection among household members of food processing and farm workers in North Carolina.

Applications

Unspecified application

Species

Unspecified reactive species

Michael Sciaudone,Melissa K Cutshaw,Colleen M McClean,Roberto Lacayo,Oksana Kharabora,Katherine Murray,Stephen Strohminger,Miriana Moreno Zivanovich,Rachel Gurnett,Alena J Markmann,Emperatriz Morales Salgado,D Ryan Bhowmik,Edwin Castro-Arroyo,Ross M Boyce,Allison E Aiello,David Richardson,Jonathan J Juliano,Natalie M Bowman

Cell reports 38:110336 PubMed35090596

2022

SARS-CoV-2 mRNA vaccine induces robust specific and cross-reactive IgG and unequal neutralizing antibodies in naive and previously infected people.

Applications

Unspecified application

Species

Unspecified reactive species

Tara M Narowski,Kristin Raphel,Lily E Adams,Jenny Huang,Nadja A Vielot,Ramesh Jadi,Aravinda M de Silva,Ralph S Baric,John E Lafleur,Lakshmanane Premkumar

Science immunology 5: PubMed32527802

2020

The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients.

Applications

Unspecified application

Species

Unspecified reactive species

Lakshmanane Premkumar,Bruno Segovia-Chumbez,Ramesh Jadi,David R Martinez,Rajendra Raut,Alena Markmann,Caleb Cornaby,Luther Bartelt,Susan Weiss,Yara Park,Caitlin E Edwards,Eric Weimer,Erin M Scherer,Nadine Rouphael,Srilatha Edupuganti,Daniela Weiskopf,Longping V Tse,Yixuan J Hou,David Margolis,Alessandro Sette,Matthew H Collins,John Schmitz,Ralph S Baric,Aravinda M de Silva

medRxiv : the preprint server for health sciences : PubMed32511572

2020

The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies.

Applications

Unspecified application

Species

Unspecified reactive species

Lakshmanane Premkumar,Bruno Segovia-Chumbez,Ramesh Jadi,David R Martinez,Rajendra Raut,Alena Markmann,Caleb Cornaby,Luther Bartelt,Susan Weiss,Yara Park,Caitlin E Edwards,Eric Weimer,Erin M Scherer,Nadine Roupael,Sri Edupuganti,Daniela Weiskopf,Longping V Tse,Yixuan J Hou,David Margolis,Alessandro Sette,Matthew H Collins,John Schmitz,Ralph S Baric,Aravinda M de Silva

NPJ vaccines 5:20 PubMed32194997

2020

Immunization of mice with chimeric antigens displaying selected epitopes confers protection against intestinal colonization and renal damage caused by Shiga toxin-producing .

Applications

Unspecified application

Species

Unspecified reactive species

David A Montero,Felipe Del Canto,Juan C Salazar,Sandra Céspedes,Leandro Cádiz,Mauricio Arenas-Salinas,José Reyes,Ángel Oñate,Roberto M Vidal
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com